Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:HUM On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeHUMHumana$400.51+3.6%$354.03$163.11▼$428.88$48.02B0.711.30 million shs2.05 million shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceHUMHumana0.00%+1.97%+10.99%+95.28%+76.74%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeHUMHumana$400.51+3.6%$354.03$163.11▼$428.88$48.02B0.711.30 million shs2.05 million shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceHUMHumana0.00%+1.97%+10.99%+95.28%+76.74%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceHUMHumana 2.39Hold$325.87-18.64% DownsideCurrent Analyst Ratings BreakdownLatest HUM Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/14/2026HUMHumana TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetHold$211.00 ➝ $350.007/14/2026HUMHumana Truist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetHold$320.00 ➝ $415.007/13/2026HUMHumana Wells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeEqual Weight ➝ Overweight$227.00 ➝ $502.007/13/2026HUMHumana Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Strong-Buy7/9/2026HUMHumana Royal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetSector Perform$246.00 ➝ $415.007/7/2026HUMHumana Raymond James FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$300.007/7/2026HUMHumana Cantor FitzgeraldSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$264.00 ➝ $300.006/29/2026HUMHumana Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold (C-) ➝ Hold (C)6/24/2026HUMHumana Bank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$340.00 ➝ $380.006/15/2026HUMHumana UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingNeutral(Data available from 7/19/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookHUMHumana$129.66B0.37$24.10 per share16.62$147.47 per share2.72Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateHUMHumana$1.19B$9.3542.8425.812.160.82%10.45%3.75%7/29/2026 (Estimated)Latest HUM EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/29/2026Q2 2026HUMHumana$7.25N/AN/AN/A$40.57 billionN/A4/29/2026Q1 2026HUMHumana$9.97$10.31+$0.34$9.83$39.37 billion$39.65 billionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthHUMHumana$3.540.88%+7.20%37.86%N/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioHUMHumana0.661.771.77Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipHUMHumana92.38%Insider OwnershipCompanyInsider OwnershipHUMHumana0.20%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableHUMHumana67,060120.06 million119.82 millionOptionableHUM HeadlinesRecent News About These CompaniesFifth Third Bancorp Has $3.98 Million Stock Position in Humana Inc. $HUM1 hour ago | marketbeat.comWatershed Asset Management L.L.C. Takes $474,000 Position in Humana Inc. $HUMJuly 18 at 6:39 AM | marketbeat.comZacks Research Weighs in on Humana's Q4 Earnings (NYSE:HUM)July 18 at 1:42 AM | americanbankingnews.comHumana AB: Humana reports second quarter and half-year 2026 resultsJuly 17 at 10:29 PM | finanznachrichten.deIs Humana (HUM) Stock Outpacing Its Medical Peers This Year?July 17 at 10:46 AM | zacks.comHumana boosts profitability and cash flow despite muted growth in Q2 2026July 17 at 2:51 AM | tipranks.comCan Humana (HUM) Run Higher on Rising Earnings Estimates?July 16 at 1:21 PM | zacks.comHumana (NYSE:HUM) Hits New 52-Week High - Here's What HappenedJuly 16 at 10:59 AM | marketbeat.comMedicare's $50 Weight-Loss Drug Window Opens In July: What Smart Enrollees Do Before 2027July 16 at 10:00 AM | benzinga.comBrokers Set Expectations for Humana's Q4 Earnings (NYSE:HUM)July 16 at 6:41 AM | marketbeat.comHumana: Q2 Earnings Must Catch Up With The StockJuly 15, 2026 | seekingalpha.comHumana (HUM) Rallies On Conflicting Valuation Views, Is It Fully Priced?July 15, 2026 | finance.yahoo.comZacks Research Issues Positive Outlook for Humana EarningsJuly 15, 2026 | marketbeat.comHumana (NYSE:HUM) Upgraded by Zacks Research to "Strong-Buy" RatingJuly 15, 2026 | marketbeat.comHumana (NYSE:HUM) Price Target Raised to $415.00 at Truist FinancialJuly 15, 2026 | americanbankingnews.comAgreement between Wexner Medical Center, Humana set to end in OctoberJuly 14, 2026 | msn.comHumana (NYSE:HUM) Price Target Raised to $415.00July 14, 2026 | marketbeat.comHumana insurance network terminating agreement with Ohio StateJuly 13, 2026 | msn.comHumana Eyes 3% Medicare Advantage Margin: Can It Deliver?July 13, 2026 | zacks.comHumana Rises as Medicare Advantage Sentiment ImprovesJuly 13, 2026 | quiverquant.comQHumana pops as Wells Fargo upgrades on moderating cost trendsJuly 13, 2026 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All Headlines5 Tech Stocks to Buy on the July PullbackBy Thomas Hughes | June 29, 2026SK Hynix’s Nasdaq Listing Could Reset the AI Memory TradeBy Thomas Hughes | July 7, 2026AirJoule Unveils Prime System, Clearing Path to CommercializationBy Thomas Hughes | July 1, 2026Agility Robotics’ SPAC Deal Opens a Rare Door Into Humanoid AIBy Jeffrey Neal Johnson | July 2, 20263 Picks-and-Shovels Stocks Powering the Humanoid Robotics BuildoutBy Ryan Hasson | July 17, 2026HUM Company DescriptionsHumana NYSE:HUM$400.51 +14.03 (+3.63%) Closing price 07/17/2026 03:59 PM EasternExtended Trading$400.00 -0.51 (-0.13%) As of 07/17/2026 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, life insurance, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; military services, such as TRICARE T2017 East Region contract; and engages in the operations of pharmacy benefit manager business. Further, it operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties. The company sells its products through employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 07/13- 07/17 The Market Sold Alcoa After Earnings—But It May Be Missing the Real Story TSMC Just Gave AI Chip Bulls Another Reason to Stay Confident Aehr Test Systems Stock Soars on Earnings, Eyes Over 150% Revenue Growth Why Intuitive Surgical’s Strong Quarter Still Spooked Investors Netflix May Be Cheap Enough to Tempt Buyers After Earnings Drop AST SpaceMobile Stock Sinks as SpaceX Fallout Rattles Space Sector Delta vs. United: Which Airline Is Better Built for Higher Fuel Costs? Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.